跳至主要内容
临床试验/NCT04126486
NCT04126486已完成4 期

GUARD-AF: reducinG Stroke by Screening for UndiAgnosed atRial Fibrillation in Elderly inDividuals

Bristol-Myers Squibb344 个研究点 分布在 1 个国家目标入组 11,931 人开始时间: 2019年12月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
11,931
试验地点
344
主要终点
Incidence of bleeding leading to hospitalization

研究概览

简要总结

The purpose of this study is to determine if an AF detection intervention in men and women at least 70 years of age with undiagnosed atrial fibrillation (AF) or atrial flutter (AFL) reduces the person-years incidence rate of stroke compared to usual care (no AF detection intervention).

详细描述

This a prospective, randomized study in primary care practices.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women at least 70 years of age who are new or established participants in the primary care practice
  • Willing to provide consent to participate in the study and to use personal health information to ascertain endpoints from the Center for Medicare & Medicaid Services (CMS) Medicare Claims Database and to access data from health records
  • Health insurance by Medicare Parts A & B (Medicare Fee-for-service)

排除标准

  • Oral anticoagulation (OAC) for any indication at the time of enrollment
  • History of Atrial Fibrillation (AF) or Atrial Flutter (AFL) as documented in the participant's current medical problem list
  • Any condition the investigator considers a contraindication to OAC, e.g., bleeding that required medical attention or severe renal impairment
  • Any condition the investigator considers will prevent compliance with study instructions
  • Implanted cardiac devices (pacemakers, implantable cardiac defibrillators, or cardiac resynchronization therapy, and implantable loop recorders)
  • History of allergy to adhesive
  • Not able to wear the Zio®XT monitor or not able to apply the monitor by herself/himself or with the help of a caregiver
  • Other protocol-defined inclusion/exclusion criteria could apply

结局指标

主要结局

Incidence of bleeding leading to hospitalization

时间窗: From 2.5 years to 5 years after study start

Incidence of all strokes leading to hospitalization

时间窗: From 2.5 years to 5 years after study start

次要结局

未报告次要终点

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry
责任方
Sponsor

研究点 (344)

Loading locations...

相似试验